BRIEF published on 10/02/2024 at 19:20, 1 day 5 hours ago Novem Group S.A. Receives Potential Delisting Acquisition Offer Frankfurt Stock Exchange Delisting Shareholder Offer Novem Group Automotive Investments
PRESS RELEASE published on 10/02/2024 at 19:15, 1 day 5 hours ago EQS-Adhoc: Novem Group S.A.: Potential delisting acquisition offer for the shares and potential delisting Novem Group S.A. is considering a potential delisting acquisition offer for shares and delisting from the Frankfurt Stock Exchange, pending board approvals. More updates to follow Shares Frankfurt Stock Exchange Delisting Novem Group S.A. Acquisition Offer
BRIEF published on 08/22/2024 at 16:35, 1 month 12 days ago Novem Group S.A.: Annual General Meeting Approves All Items on the Agenda Annual General Meeting Voting Results Dividend Supervisory Board Novem Group
PRESS RELEASE published on 08/22/2024 at 16:30, 1 month 12 days ago Novem Group S.A.: Annual General Meeting approves all items on the agenda Novem Group S.A. shareholders approve all agenda items at the Annual General Meeting, appoint new Supervisory Board member, and decide not to distribute dividend for FY 2023/24 due to market conditions Annual General Meeting Shareholders Dividend Novem Group S.A. New Member
BRIEF published on 08/14/2024 at 09:05, 1 month 20 days ago Novem Group S.A.: Q1 2024/25 Figures Show a Soft Start to the Year Financial Performance Market Conditions Revenue Decrease Q1 Results Novem Group
PRESS RELEASE published on 08/14/2024 at 09:00, 1 month 20 days ago Novem Group S.A.: Q1 2024/25 figures show a soft start to the year Novem Group S.A. reports a soft start with Q1 2024/25 figures showing a revenue decline of 20.0% and Adj. EBIT decrease of 29.2% compared to the previous year amidst challenging market conditions Financial Results Revenue Decline Novem Group S.A. Challenging Market Conditions Q1 2024/25
BRIEF published on 08/07/2024 at 09:05, 1 month 27 days ago Novem Group S.A.: Invitation to the Q1 2024/25 Results Presentation on 14 August 2024 Conference Call Investor Relations Results Presentation Novem Group Q1 2024/25
PRESS RELEASE published on 08/07/2024 at 09:00, 1 month 27 days ago Novem Group S.A.: Invitation to the Q1 2024/25 results presentation on 14 August 2024 Novem Group S.A. invites investors and analysts to the Q1 2024/25 results presentation on 14 August 2024, with CEO Markus Wittmann and CFO Dr. Johannes Burtscher presenting Investors Analysts Presentation Q1 Results Novem Group
BRIEF published on 08/01/2024 at 08:02, 2 months 2 days ago Novem Group S.A.: Changes in Management Board CFO COO Management Change Board Appointments Novem Group
BRIEF published on 08/01/2024 at 08:01, 2 months 2 days ago Novem Group S.A.: Changes in Management Board Corporate Governance Management Board Leadership Change Novem Group Company News
Published on 10/03/2024 at 23:00, 2 hours 6 minutes ago 1933 Industries to Trade on the Pink Open Market
Published on 10/03/2024 at 23:00, 2 hours 6 minutes ago CMG Home Loans Announces the Opening of New Tampa Branch
Published on 10/03/2024 at 22:45, 2 hours 21 minutes ago Rektron Schedules Annual General and Special Meeting of Shareholders in Response to Shareholder Requisition
Published on 10/03/2024 at 22:30, 2 hours 36 minutes ago Line5 Earns Top Honors for Fourth Consecutive Year at the 2024 Dealers' Choice Awards
Published on 10/03/2024 at 22:17, 2 hours 49 minutes ago abrdn Asia-Pacific Income Fund, Inc. (FAX) Announces Issuance Of Series B Mandatory Redeemable Preferred Shares
Published on 10/03/2024 at 22:01, 3 hours 4 minutes ago Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Published on 10/03/2024 at 22:01, 3 hours 5 minutes ago Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
Published on 10/03/2024 at 21:57, 3 hours 8 minutes ago EQS-Adhoc: Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Published on 10/03/2024 at 18:45, 6 hours 21 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/03/2024 at 17:45, 7 hours 21 minutes ago Aéroports de Paris SA - Voting rights as of 30 September 2024
Published on 10/03/2024 at 17:45, 7 hours 21 minutes ago CHARGEURS - Voting rights monthly statement as of September 30th, 2024
Published on 10/03/2024 at 17:42, 7 hours 23 minutes ago Mersen: Number of shares and voting rights as of September 30, 2024
Published on 10/03/2024 at 08:00, 17 hours 5 minutes ago KURMA PARTNERS ACHIEVES FIRST CLOSE OF NEW EUR 250 MILLION BIOFUND IV
Published on 10/02/2024 at 18:50, 1 day 6 hours ago AXA: Elimination of the dilutive impact of Shareplan 2024
